Sugie H, Sugie Y, Akimoto H, Endo K, Shirai M, Ito M
Department of Pediatrics, Hamamatsu University School of Medicine, Japan.
Acta Paediatr. 1992 Apr;81(4):371-2. doi: 10.1111/j.1651-2227.1992.tb12248.x.
We report a 14-month-old male with infantile opsoclonus polymyoclonia syndrome. His clinical disabilities responded favorably to high-dose human immunoglobulin therapy. High dose immunoglobulin therapy is one of the therapies for patients with this syndrome.
我们报告了一名患有婴儿性眼球阵挛-肌阵挛综合征的14个月大男性。他的临床残疾状况对大剂量人免疫球蛋白治疗反应良好。大剂量免疫球蛋白治疗是该综合征患者的治疗方法之一。
